Redlen Technologies manufactures high-resolution Cadmium Zinc Telluride (CZT) semiconductor radiation detectors that enable reduced radiation dose, improved image resolution, and greater diagnostic accuracy. Its detectors are deployed in advanced nuclear cardiology, nuclear breast imaging, nuclear surgical probes, and precision handheld dirty bomb detectors. The company completed a $5.5 million equity financing led by Pangaea Ventures with participation from other major investors including In-Q-Tel. Proceeds will be used to expand Redlen's product line and volume production capabilities for its precision radiation imaging and detection products. The financing will enable completion of development to commercialize new detectors for medical CT imaging, bone densitometers, dental imaging, and advanced baggage scanning able to accurately detect liquid or homemade explosives. Redlen is based in Saanichton, British Columbia, and has added Chris Erickson of Pangaea Ventures to its board. Redlen Technologies designs and manufactures high-resolution Cadmium‑Zinc‑Telluride (CZT) semiconductor radiation detector products. Its CZT detectors directly convert radiation to electrical signals, improving energy resolution and image quality while operating at room temperature for compact, portable instruments. Redlen has a scalable, high-volume production process for CZT wafers using its proprietary Traveling Heater Method (THM) technology. The company targets security and medical markets with applications including dirty bomb detection, cargo inspection, nuclear isotope identification, airport baggage screening, SPECT/PET, photon‑counting CT, and X‑ray imaging. Following the IQT agreement, Redlen plans to accelerate product development and commercial deployment for defense and security customers. The partnership is intended to broaden the breadth of detector products and enable easier OEM integration and faster time‑to‑market.

Total raised

$6M

Funding rounds

2

Latest round

Equity

Latest activity

Mar 2014